Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
$11.52
$11.50
$5.57
$11.98
$397.94M1.11106,940 shs9,831 shs
Ardent Health, Inc. stock logo
ARDT
Ardent Health
$10.21
-3.7%
$13.04
$10.10
$20.72
$1.52BN/A470,005 shs470,053 shs
Clover Health Investments, Corp. stock logo
CLOV
Clover Health Investments
$2.78
-3.8%
$2.97
$1.50
$4.87
$1.47B1.919.57 million shs7.37 million shs
Phreesia, Inc. stock logo
PHR
Phreesia
$26.31
-2.4%
$26.82
$17.07
$30.53
$1.60B0.71441,135 shs433,179 shs
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
0.00%0.00%0.00%0.00%0.00%
Ardent Health, Inc. stock logo
ARDT
Ardent Health
-3.42%-7.60%-24.09%-22.53%-42.93%
Clover Health Investments, Corp. stock logo
CLOV
Clover Health Investments
-3.81%-8.55%+7.34%-16.77%+45.55%
Phreesia, Inc. stock logo
PHR
Phreesia
-2.44%-1.16%-9.56%+2.49%+5.45%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
N/AN/AN/AN/AN/AN/AN/AN/A
Ardent Health, Inc. stock logo
ARDT
Ardent Health
3.6115 of 5 stars
3.50.00.00.02.60.03.8
Clover Health Investments, Corp. stock logo
CLOV
Clover Health Investments
3.0068 of 5 stars
3.33.00.00.03.32.50.6
Phreesia, Inc. stock logo
PHR
Phreesia
4.2023 of 5 stars
3.53.00.04.22.02.50.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
0.00
N/AN/AN/A
Ardent Health, Inc. stock logo
ARDT
Ardent Health
2.92
Moderate Buy$20.3098.82% Upside
Clover Health Investments, Corp. stock logo
CLOV
Clover Health Investments
2.67
Moderate Buy$4.8373.86% Upside
Phreesia, Inc. stock logo
PHR
Phreesia
3.09
Buy$32.2722.66% Upside

Current Analyst Ratings Breakdown

Latest ARA, CLOV, PHR, and ARDT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/22/2025
Phreesia, Inc. stock logo
PHR
Phreesia
DA Davidson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
7/16/2025
Ardent Health, Inc. stock logo
ARDT
Ardent Health
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeNeutral ➝ Underperform$15.50 ➝ $14.60
7/14/2025
Phreesia, Inc. stock logo
PHR
Phreesia
KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$28.00 ➝ $35.00
5/29/2025
Phreesia, Inc. stock logo
PHR
Phreesia
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$34.00 ➝ $35.00
5/29/2025
Phreesia, Inc. stock logo
PHR
Phreesia
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$35.00 ➝ $34.00
5/28/2025
Phreesia, Inc. stock logo
PHR
Phreesia
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
5/20/2025
Ardent Health, Inc. stock logo
ARDT
Ardent Health
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$21.00 ➝ $21.00
5/15/2025
Ardent Health, Inc. stock logo
ARDT
Ardent Health
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$21.00 ➝ $21.00
5/9/2025
Ardent Health, Inc. stock logo
ARDT
Ardent Health
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$16.00 ➝ $18.00
(Data available from 8/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
$822.52M0.48$1.69 per share6.80$2.59 per share4.45
Ardent Health, Inc. stock logo
ARDT
Ardent Health
$5.97B0.24$2.44 per share4.18$10.66 per share0.96
Clover Health Investments, Corp. stock logo
CLOV
Clover Health Investments
$1.37B1.03N/AN/A$0.68 per share4.09
Phreesia, Inc. stock logo
PHR
Phreesia
$419.81M3.73N/AN/A$4.56 per share5.77
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
-$13.79M$0.26N/AN/AN/A-2.04%-3.56%-0.24%N/A
Ardent Health, Inc. stock logo
ARDT
Ardent Health
$210.34M$1.636.265.214.443.73%16.07%4.69%8/5/2025 (Estimated)
Clover Health Investments, Corp. stock logo
CLOV
Clover Health Investments
-$43.01M-$0.05N/AN/AN/A-1.69%-7.42%-4.00%8/5/2025 (Estimated)
Phreesia, Inc. stock logo
PHR
Phreesia
-$58.53M-$0.74N/AN/AN/A-9.83%-16.23%-11.19%9/3/2025 (Estimated)

Latest ARA, CLOV, PHR, and ARDT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/5/2025Q2 2025
Ardent Health, Inc. stock logo
ARDT
Ardent Health
$0.51N/AN/AN/A$1.54 billionN/A
8/5/2025Q2 2025
Clover Health Investments, Corp. stock logo
CLOV
Clover Health Investments
$0.03N/AN/AN/A$468.30 millionN/A
5/28/2025Q1 2026
Phreesia, Inc. stock logo
PHR
Phreesia
-$0.13-$0.07+$0.06-$0.07$115.00 million$115.94 million
5/6/2025Q1 2025
Ardent Health, Inc. stock logo
ARDT
Ardent Health
$0.21$0.29+$0.08$0.29$1.50 billion$1.50 billion
5/6/2025Q1 2025
Clover Health Investments, Corp. stock logo
CLOV
Clover Health Investments
-$0.07$0.05+$0.12N/A$466.93 million$462.33 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
N/AN/AN/AN/AN/A
Ardent Health, Inc. stock logo
ARDT
Ardent Health
N/AN/AN/AN/AN/A
Clover Health Investments, Corp. stock logo
CLOV
Clover Health Investments
N/AN/AN/AN/AN/A
Phreesia, Inc. stock logo
PHR
Phreesia
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
7.54
1.05
1.02
Ardent Health, Inc. stock logo
ARDT
Ardent Health
0.70
2.12
1.98
Clover Health Investments, Corp. stock logo
CLOV
Clover Health Investments
N/A
1.54
1.54
Phreesia, Inc. stock logo
PHR
Phreesia
0.02
1.95
1.95

Institutional Ownership

CompanyInstitutional Ownership
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
78.42%
Ardent Health, Inc. stock logo
ARDT
Ardent Health
N/A
Clover Health Investments, Corp. stock logo
CLOV
Clover Health Investments
19.77%
Phreesia, Inc. stock logo
PHR
Phreesia
92.10%

Insider Ownership

CompanyInsider Ownership
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
9.50%
Ardent Health, Inc. stock logo
ARDT
Ardent Health
1.70%
Clover Health Investments, Corp. stock logo
CLOV
Clover Health Investments
24.07%
Phreesia, Inc. stock logo
PHR
Phreesia
5.50%
CompanyEmployeesShares OutstandingFree FloatOptionable
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
4,97734.54 millionN/AOptionable
Ardent Health, Inc. stock logo
ARDT
Ardent Health
24,900143.04 million140.61 millionOptionable
Clover Health Investments, Corp. stock logo
CLOV
Clover Health Investments
680508.92 million386.42 millionOptionable
Phreesia, Inc. stock logo
PHR
Phreesia
2,08259.50 million56.23 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
American Renal Associates stock logo

American Renal Associates NYSE:ARA

American Renal Associates Holdings, Inc. operates as a dialysis services provider in the United States. It operates dialysis clinics focusing on joint venture partnerships with physicians. The company offers kidney dialysis services to patients suffering from chronic kidney failure or end stage renal disease. As of December 31, 2019, it operated 246 dialysis clinics in partnership with 400 nephrologist partners treating approximately 17,300 patients in 27 states and the District of Columbia. The company was founded in 1999 and is headquartered in Beverly, Massachusetts.

Ardent Health stock logo

Ardent Health NYSE:ARDT

$10.21 -0.39 (-3.68%)
Closing price 08/1/2025 03:59 PM Eastern
Extended Trading
$10.54 +0.32 (+3.18%)
As of 08/1/2025 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Ardent Health Partners, Inc. owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health Partners, Inc. is a subsidiary of EGI-AM Investments, L.L.C.

Clover Health Investments stock logo

Clover Health Investments NASDAQ:CLOV

$2.78 -0.11 (-3.81%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$2.80 +0.02 (+0.54%)
As of 08/1/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat. Clover Health Investments, Corp. is based in Franklin, Tennessee.

Phreesia stock logo

Phreesia NYSE:PHR

$26.31 -0.65 (-2.41%)
Closing price 08/1/2025 03:59 PM Eastern
Extended Trading
$26.34 +0.03 (+0.10%)
As of 08/1/2025 05:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is based in Wilmington, Delaware.